Diabetes and microvascular pathophysiology: role of epidermal growth factor receptor tyrosine kinase.
about
Renal autoregulation in health and diseaseNonhuman primates and other animal models in diabetes research.Transactivation of ErbB Family of Receptor Tyrosine Kinases Is Inhibited by Angiotensin-(1-7) via Its Mas Receptor.Chronic inhibition of epidermal growth factor receptor tyrosine kinase and extracellular signal-regulated kinases 1 and 2 (ERK1/2) augments vascular response to limb ischemia in type 2 diabetic mice.Metabolic syndrome impairs reactivity and wall mechanics of cerebral resistance arteries in obese Zucker rats.The epidermal growth factor receptor and its ligands in cardiovascular disease.The prelude on novel receptor and ligand targets involved in the treatment of diabetes mellitus.SVMRFE based approach for prediction of most discriminatory gene target for type II diabetes.The role of epidermal growth factor receptor in diabetes-induced cardiac dysfunction.Diabetic cardiomyopathy: Role of epidermal growth factor receptor tyrosine kinase.The C-terminal module IV of connective tissue growth factor, through EGFR/Nox1 signaling, activates the NF-κB pathway and proinflammatory factors in vascular smooth muscle cells.11β-HSD1 inhibition ameliorates diabetes-induced cardiomyocyte hypertrophy and cardiac fibrosis through modulation of EGFR activity.Essential role for EGFR tyrosine kinase and ER stress in myocardial infarction in type 2 diabetes.The dual targeting of EGFR and ErbB2 with the inhibitor Lapatinib corrects high glucose-induced apoptosis and vascular dysfunction by opposing multiple diabetes-induced signaling changes.
P2860
Q28082365-1A9525C5-5118-4046-B6FE-C06DEA4CCF81Q34286456-BE614952-EA9E-459D-8A64-DBE30DCD4A21Q34500492-ECE6E2B5-EF57-4C12-98C3-907CDE791120Q35917666-4CBE009F-FB9C-4A8A-B2D5-E74323683468Q36422434-276BED9E-03E4-4EF3-831A-0B3082944C1AQ37291330-4041FBB1-EAE8-4C41-9446-06C5FE2B6385Q37712484-DB7E2245-AA13-4D36-B445-8261ECAAE5C7Q38919462-3F71BD69-15AE-46BB-8D7C-15BEABAF4D9CQ40552347-6DD29E27-1A6C-4D7B-BF05-327F9E5949CFQ42324509-1C2E39CC-86B9-4A56-A3FC-70B3A904C202Q42876722-52951D95-907C-4599-939F-91CBBE3CB8DFQ47094783-DA354279-BC75-4817-9E43-01A4294F9408Q49484658-3765D3D6-1EFE-42A1-850F-B62786AA2E01Q50959754-230496DD-677E-440F-9332-8608117A33C3
P2860
Diabetes and microvascular pathophysiology: role of epidermal growth factor receptor tyrosine kinase.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Diabetes and microvascular pat ...... ctor receptor tyrosine kinase.
@ast
Diabetes and microvascular pat ...... ctor receptor tyrosine kinase.
@en
type
label
Diabetes and microvascular pat ...... ctor receptor tyrosine kinase.
@ast
Diabetes and microvascular pat ...... ctor receptor tyrosine kinase.
@en
prefLabel
Diabetes and microvascular pat ...... ctor receptor tyrosine kinase.
@ast
Diabetes and microvascular pat ...... ctor receptor tyrosine kinase.
@en
P2860
P356
P1476
Diabetes and microvascular pat ...... ctor receptor tyrosine kinase.
@en
P2093
Khalid Matrougui
P2860
P356
10.1002/DMRR.1050
P577
2010-01-01T00:00:00Z